Modulating Fingolimod (FTY720) Anti-SARS-CoV-2 Activity Using a PLGA-Based Drug Delivery System

Renata Rank Miranda; Natália Noronha Ferreira; Edmarcia Elisa de Souza; Paula Maria Pincela Lins; Leonardo Miziara Barboza Ferreira; Arne Krüger; Valéria Maria de Oliveira Cardoso; Edison Luiz Durigon; Carsten Wrenger; Valtencir Zucolotto

doi:10.1021/acsabm.2c00349

journal article Jun 22, 2022

Modulating Fingolimod (FTY720) Anti-SARS-CoV-2 Activity Using a PLGA-Based Drug Delivery System

Renata Rank Miranda

Natália Noronha Ferreira Edmarcia Elisa de Souza Paula Maria Pincela Lins

Leonardo Miziara Barboza Ferreira Arne Krüger

Valéria Maria de Oliveira Cardoso Edison Luiz Durigon Carsten Wrenger

Valtencir Zucolotto

ACS Applied Bio Materials Vol. 5 No. 7 pp. 3371-3383 · American Chemical Society (ACS)

View at Publisher Save 10.1021/acsabm.2c00349

Topics

No keywords indexed for this article. Browse by subject →

References

69

[1]

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu, Dingyu Zhang, Wenling Wang et al.

New England Journal of Medicine 10.1056/nejmoa2001017

[2]

10.1016/j.msard.2020.102512

[3]

10.1111/dth.13477

[4]

10.1016/j.biopha.2021.111272

[5]

10.1038/s41467-021-21134-2

[6]

10.1016/s0140-6736(21)02125-5

[7]

10.1038/s41591-020-1124-9

[8]

10.1038/s41598-021-82833-w

[9]

10.1016/j.crphar.2022.100086

[10]

10.1186/s40001-021-00626-3

[11]

10.1128/cmr.00109-21

[12]

10.1007/s12250-021-00404-9

[13]

10.1016/j.cclet.2021.04.008

[14]

U.S. Food and Drug Administration. Coronavirus (COVID-19)|Drugs─COVID-19 Therapeutics. https://www.fda.gov/drugs/emergency-preparedness-drugs/coronavirus-covid-19-drugs (accessed 2022-05-31).

[15]

10.1016/j.ejphar.2020.173644

[16]

10.1007/s43440-020-00155-6

[17]

10.1016/j.msard.2020.102180

[18]

10.1016/j.jneuroim.2018.07.008

[19]

10.1038/s41598-021-93857-7

[20]

10.1016/j.phymed.2020.153311

[21]

10.1016/j.nano.2013.08.001

[22]

10.1080/03639045.2017.1386194

[23]

10.1038/s41598-017-06142-x

[24]

10.3109/10837450.2015.1108982

[25]

10.1016/j.jconrel.2021.06.036

[26]

10.3389/fnano.2020.588915

[27]

10.1007/s13346-020-00824-2

[28]

Ghediya R. V. J. Chem. Pharm. Res. (2016)

[29]

10.1016/j.xphs.2018.11.038

[30]

10.1016/j.carbpol.2020.117435

[31]

10.1590/0074-02760200342

[32]

10.1177/1087057106296688

[33]

10.1016/j.jviromet.2011.02.002

[34]

10.2807/1560-7917.es.2020.25.3.2000045

[35]

10.1038/nrd.2018.168

[36]

10.1016/j.jconrel.2012.01.043

[37]

10.1038/s41467-021-24872-5

[38]

10.1038/s41467-021-25982-w

[39]

10.1111/ejn.15391

[40]

10.1111/j.2042-7158.1972.tb08930.x

[41]

10.1016/0378-5173(83)90064-9

[42]

10.1016/j.jconrel.2014.06.041

[43]

10.1016/j.ijpharm.2005.10.044

[44]

10.1016/j.ijpharm.2021.120714

[45]

10.1016/j.heliyon.2020.e03451

[46]

10.3892/or.2016.4668

[47]

10.4161/cbt.28556

[48]

10.1016/j.tranon.2020.100926

[49]

10.2147/ijn.s156328

[50]

10.1101/2020.08.12.246389

Showing 50 of 69 references

Cited By

12

Experimental and Theoretical Investigation of Inclusion Complexes of β-Cyclodextrin with Fingolimod

A. A. Garibyan, E. S. Delyagina · 2023

Russian Journal of Physical Chemist...

Metrics

12

Citations

69

References

Details

Published: Jun 22, 2022
Vol/Issue: 5(7)
Pages: 3371-3383
License: View

Authors

R

Renata Rank Miranda

Nanomedicine and Nanotoxicology Group, Physics Institute of São Carlos, São Paulo University, Avenida Trabalhador São Carlense, 400, 13566-590 São Carlos, São Paulo, Brazil

N

Natália Noronha Ferreira

Nanomedicine and Nanotoxicology Group, Physics Institute of São Carlos, São Paulo University, Avenida Trabalhador São Carlense, 400, 13566-590 São Carlos, São Paulo, Brazil

E

Edmarcia Elisa de Souza

Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes 1374, 05508-000 Sao Paulo, Sao Paulo, Brazil

P

Paula Maria Pincela Lins

Nanomedicine and Nanotoxicology Group, Physics Institute of São Carlos, São Paulo University, Avenida Trabalhador São Carlense, 400, 13566-590 São Carlos, São Paulo, Brazil

L

Leonardo Miziara Barboza Ferreira

Nanomedicine and Nanotoxicology Group, Physics Institute of São Carlos, São Paulo University, Avenida Trabalhador São Carlense, 400, 13566-590 São Carlos, São Paulo, Brazil

A

Arne Krüger

Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes 1374, 05508-000 Sao Paulo, Sao Paulo, Brazil

V

Valéria Maria de Oliveira Cardoso

Nanomedicine and Nanotoxicology Group, Physics Institute of São Carlos, São Paulo University, Avenida Trabalhador São Carlense, 400, 13566-590 São Carlos, São Paulo, Brazil

E

Edison Luiz Durigon

Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes 1374, 05508-000 Sao Paulo, Sao Paulo, Brazil

C

Carsten Wrenger

Unit for Drug Discovery, Department of Parasitology, Institute of Biomedical Sciences, University of Sao Paulo, Av. Prof. Lineu Prestes 1374, 05508-000 Sao Paulo, Sao Paulo, Brazil

V

Valtencir Zucolotto

Nanomedicine and Nanotoxicology Group, Physics Institute of São Carlos, São Paulo University, Avenida Trabalhador São Carlense, 400, 13566-590 São Carlos, São Paulo, Brazil

Cite This Article

Renata Rank Miranda, Natália Noronha Ferreira, Edmarcia Elisa de Souza, et al. (2022). Modulating Fingolimod (FTY720) Anti-SARS-CoV-2 Activity Using a PLGA-Based Drug Delivery System. ACS Applied Bio Materials, 5(7), 3371-3383. https://doi.org/10.1021/acsabm.2c00349

Modulating Fingolimod (FTY720) Anti-SARS-CoV-2 Activity Using a PLGA-Based Drug Delivery System

You May Also Like